The preceding data suggest that AKT2 differentially promotes the metastatic potential of melanomas, but to address the mechanism, we utilized a set of human melanoma cell lines driven by mutation in BRAF, as well as by PTEN loss. The gene discussed is PTEN; the disease is melanoma.